Peter Carney > White & Case LLP > Washington DC, United States > Lawyer Profile

Marshalling its ‘strong experience’ in the life sciences sector, White & Case LLP handles large transactions and associated antitrust matters, with additional experience in IP litigation, covering Hatch-Waxman and BPCIA disputes. Peter Carney heads the group, specializing in both civil and criminal antitrust defense, cartel investigations in the US and a range of other countries, and negotiating patent settlement agreements.

Housing a ‘great international practice’, White & Case LLP regularly acts for US-based companies in international cartel proceedings, and is geared to handle both criminal proceedings and linked damage claims.  The representation of international clients in matters related to the Sherman Act is another noted specialism of the team, and includes vast experience with summary dispositions, trials and appeals in US courts. Exemplifying this in particular is practice head and trial expert Mark Gidley, who recently represented clients from the fintech, education, financial services and energy sectors. Pharmaceutical companies benefit from the firm’s dedicated pharmaceuticals and healthcare group, which is led by Peter Carney, and offers niche expertise in investigation and antitrust litigation concerning allegations of product hopping in this sector. Adam Acosta is another name to note, focusing on government investigations and antitrust litigation. All mentioned lawyers are based in Washington DC.

The ‘overall excellent‘ antitrust offering at White & Case LLP fields a team of ‘strategic, skilled litigators’ with a strong track record advising large global corporations, leading US universities, and public investment funds in the full range of high-profile antitrust litigation. Under the leadership of J. Mark Gidley, the team has recently secured several class action wins for clients in the pharma and tech industries; Kathryn Jordan Mims is another key name here. Christopher Curran takes point on cross-border disputes and litigated mergers, while New York’s Jack Pace is the key name for competitor-on-competitor disputes and pay-for-delay cases. Peter Carney, who also heads the firm’s global pharmaceuticals and healthcare group, has extensive experience representing both domestic and international corporations in investigations, patent-related antitrust litigation, and reverse-payment claims. The ‘consistently reliable‘ Jaclyn Philips and ‘true rockstar’ Kelly Newman, based in Boston, ably assists with contentious mandates in the pharma, energy, and metallurgy industries. Unless otherwise stated, all mentioned individuals are based in Washington DC.